Cybin announces completion of previously announced share consolidation

Toronto--(business wire)--cybin inc. (nyse american: cybn) (cboe ca:cybn) (“cybin” or the “company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce that it has filed articles of amendment to consolidate the company's issued and outstanding common shares (the “common shares”) on the basis of one new common share for every 38 existing common shares (the.
CYBN Ratings Summary
CYBN Quant Ranking